Spanish biotechnology companies and Biotools, BlackBio 2B, to reach an agreement of collaboration with the Mexican pharmaceutical laboratories Silanes.

– after this agreement, Laboratorios Silanes may manufacture and market diagnostic systems patented by Spanish companiesas well as develop new products and systems based on the transferred technologies

Spain, March 2012.- Biotools and 2B BlackBio Spanish companies have signed a global agreement of product license and transfer of technology in the fields of molecular diagnostics and personalized medicine with the Mexican pharmaceutical laboratories Silanes.

This agreement will allow Laboratorios Silanes to manufacture and sell diagnostic kits based on the technologies of amplification of nucleic acids and stabilization of complex reaction mixtures ( Gelation ”) patented by Biotools, and directed microarrays exact genetic material patented by BlackBio technologiesas well as develop new products and systems based on the transferred technologies, with application in the diagnosis microbiological, pharmacogenetics and preventive and personalized medicine.

Laboratorios Silanes, with 68 years of experience in the pharmaceutical market and prescription that invests 10% of its sales in research and development at national and international level in countries such as Spain and United States and has a portfolio of 100 products for the health in their country of originMexico, is the leading manufacturer of combined oral antidiabetic agents, to produce annually thousand 360 million tablets, with what daily serves a million patients living with diabetes mellitus type 2 in Mexico, South America, Central America and the Caribbean. In the field of biotechnology is an international leader in research, development, manufacture and marketing of Faboterápicos protected by international patents and is the only company in Latin America to obtain a record before the FDA for an innovative biotechnological product.

Founded in 2009, 2B BlackBio SL offers solutions through its patented technology of microarrays directed accurate in the fields of preventive and personalized medicine, medical diagnosis, and pharmacogenomics, focusing its developments in the areas of Oncology, cardiovascular, metabolism and microbiology. also, BlackBio 2B has a division of applied geneticsGenotest, which offers a wide range of services for genetic analysis in the fields of nutrition, sport, metabolic diseases, cardiovascular disorders and personalized treatment of cancer.

Biotools B & M Labs, SA, headquartered in Spain and a subsidiary in Brazil, is one of the main companies of biotechnology in the field of reagents, applications and technologies of molecular biology in Europe. It has a global sales network in Latin America and Asia, with a wide range of products and international patents.